Orgovyx 120 mg – DIN 02542137
Orgovyx is Relugolix 120 mg (tablet), sold in Canada. It is used for prostate cancer. It is supplied by Knight Therapeutics Inc. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.
Sold in Canada
Relugolix 120 mg
- Brand
- Orgovyx
- Strength
- 120 mg
- Used for
- Prostate cancer
- Form
- Tablet
- Manufacturer
- Knight Therapeutics Inc
- Drug class
- Gonadotropin releasing hormone receptor antagonist
- Sold in
- Canada
- DIN
- 02542137
Source: Health Canada's Drug Product Database. Last checked .
Report a mistake
What is Relugolix used for?
Relugolix is used for prostate cancer.
- Medicine type
- Gonadotropin releasing hormone receptor antagonist
Official uses from the US prescribing label
ORGOVYX is indicated for the treatment of adult patients with advanced prostate cancer.
From the FDA-approved label on DailyMed (published Nov 17, 2025).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your medicine? Check the box
- The box or bottle shows DIN 02542137.
- It names Orgovyx, Relugolix 120 mg.
- A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.
Sold in Canada as Orgovyx by Knight Therapeutics Inc..
In Canada: prescription only.
Ingredients
Active: Relugolix